|
PIGF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55989999994777E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.96129999999429E-05 |
| Normal-vs-Stage2 |
1.016200E-03 |
| Normal-vs-Stage3 |
2.52219999996584E-07 |
| Normal-vs-Stage4 |
1.31329999986107E-07 |
| Stage1-vs-Stage2 |
7.701400E-01 |
| Stage1-vs-Stage3 |
3.154100E-02 |
| Stage1-vs-Stage4 |
1.145900E-02 |
| Stage2-vs-Stage3 |
2.425800E-01 |
| Stage2-vs-Stage4 |
8.755800E-02 |
| Stage3-vs-Stage4 |
4.114800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.57629999958986E-07 |
| Normal-vs-AfricanAmerican |
3.645000E-03 |
| Normal-vs-Asian |
1.055850E-03 |
| Caucasian-vs-AfricanAmerican |
6.659600E-01 |
| Caucasian-vs-Asian |
4.223400E-01 |
| AfricanAmerican-vs-Asian |
8.729000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.9236999998794E-07 |
| Normal-vs-Female |
2.01569999999096E-05 |
| Male-vs-Female |
5.796200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.645380E-04 |
| Normal-vs-Age(41-60Yrs) |
1.87618999999417E-05 |
| Normal-vs-Age(61-80Yrs) |
1.05039999998002E-06 |
| Normal-vs-Age(81-100Yrs) |
5.136400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.237400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.322000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.678000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.808000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.266800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.226200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.356800E-03 |
| Classical-VS-Follicular |
7.871200E-01 |
| Classical-VS-Other |
6.044000E-01 |
| Classical-VS-Normal |
1.63534999999548E-05 |
| Tall-VS-Follicular |
3.238400E-02 |
| Tall-VS-Other |
4.407600E-01 |
| Tall-VS-Normal |
1.06050000003854E-07 |
| Follicular-VS-Other |
7.644400E-01 |
| Follicular-VS-Normal |
3.401500E-04 |
| Other-VS-Normal |
2.983900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.28819999999308E-05 |
| Normal-vs-N1 |
1.32990000123456E-08 |
| N0-vs-N1 |
4.882800E-03 |
|
|
